September 25, 2025 International Ataxia Awareness Day: Advancing Hope Through Collaboration and Innovation Every year on September 25, the global community comes together to recognize International Ataxia Awareness Day...
July 16, 2025 Characterizing Tau Accumulation and Amyloid-tau Interactions in the Alzheimer’s Prevention Initiative Autosomal Dominant Alzheimer’s Disease Colombia Trial and Their Implications for Advancing Drug Development
July 16, 2025 Impact of non-linear SUVR transformations on the statistical power of tau-PET longitudinal studies
June 17, 2025 Honoring Progress and Hope Amidst Alzheimer’s and Brain Awareness Month Each June, we come together to recognize Alzheimer’s and Brain Awareness Month—a time to raise visibility for the 55 million..
May 15, 2025 From Awareness to Action: How C-Path’s HD-RSC Is Transforming the Future of Huntington’s Disease May 15, marks Huntington’s Disease Awareness Day, a key moment during Huntington’s Awareness...
April 25, 2025 C-Path’s Stephenson Featured in BioCentury Article C-Path Vice President of Neurology and Executive Director of Critical Path for Parkinson's (CPP) Consortium...
April 2, 2025 C-Path’s Stephenson Appears on Xtalks’ Life Science Podcast to Talk Future of Drug Development in Parkinson’s, Alzheimer’s C-Path's Diane Stephenson recently appeared on the Xtalks Life Science Podcast...
March 10, 2025 C-Path’s Critical Path for Parkinson’s Consortium Welcomes CND Life Sciences C-Path is excited to welcome CND Life Sciences as the newest member of it Critical Path for Parkinson’s (CPP)...
August 20, 2024 C-Path Receives Data Transfer from The Champ Foundation Registry C-Path has received its first data transfer of natural history data on single large-scale mitochondrial DNA...
